nach oben

Erschienen in:

10.05.2019 | Original articles

Pericardial complications and postcardiac injury syndrome after cardiovascular implantable electronic device placement

A meta-analysis and systematic review

verfasst von: B. R. Verma, MD, K. Banerjee, MD, A. Noll, MD, C. K. Ala, MD, M. Badar, MD, D. Kwon, MD, C. L. Jellis, MD, R. Hachamovitch, MD, A. Hussein, MD, Dr. A. L. Klein, MD

Erschienen in: Herz | Sonderheft 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Postcardiac injury syndrome (PCIS) is an emerging condition including pericarditis with or without pericardial effusion after an injury to cardiac tissue. Data are lacking on its incidence and clinical predictors after cardiovascular implantable electronic device (CIED) placement. We therefore performed this meta-analysis to determine the incidence of PCIS.

Methods

Medline, Embase, and Cochrane CENTRAL databases were searched according to PRISMA guidelines from February 2007 to February 2017 for studies evaluating pericardial complications subsequent to CIED implantation. Primary outcome was the total number of cases of pericarditis, pericardial effusion, and cardiac tamponade documented.

Results

Of 2931 references, 22 articles (enrolling 188,944 patients) were included. Pooled estimates from random-effects analysis showed an overall incidence of 5.82 per 1000 patients (95% confidence interval [CI], 4.33–8.17) at 30 days, and 1.60 per 1000 (95% CI: 0.13–3.07) at 1 year. Advanced age and prior coronary artery bypass graft (CABG) surgery were associated with increased rates of pericardial complications.

Conclusion

Our analysis revealed that CIED implantations are associated with a low incidence (0.6%) of pericardial complications at 30 days. Patients with advanced age and prior CABG are high-risk patients for pericardial complications.

Imazio M, Negro A, Belli R et al (2009) Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol 103(11):1525–1529. https://doi.org/10.1016/j.amjcard.2009.01.366CrossRefPubMed

Imazio M, Brucato A, Rovere ME et al (2011) Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol 108(8):1183–1187. https://doi.org/10.1016/j.amjcard.2011.06.025CrossRefPubMed

Heath R, Reece TB, Shakar S, Lindenfeld J (2011) Post-pericardial injury syndrome after continuous-flow ventricular assistance. J Heart Lung Transplant 30(6):726–729. https://doi.org/10.1016/j.healun.2011.01.719CrossRefPubMed

Persson R, Earley A, Garlitski AC, Balk EM, Uhlig K (2014) Adverse events following implantable cardioverter defibrillator implantation: A systematic review. J Interv Card Electrophysiol 40(2):191–205. https://doi.org/10.1007/s10840-014-9913-zCrossRefPubMed

Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC (2014) Complications after cardiac implantable electronic device implantations: An analysis of a complete, nationwide cohort in Denmark. Eur Heart J 35(18):1186–1194. https://doi.org/10.1093/eurheartj/eht511CrossRefPubMed

Cremer PC, Kumar A, Kontzias A et al (2016) Complicated pericarditis: Understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol 68(21):2311–2328. https://doi.org/10.1016/j.jacc.2016.07.785CrossRefPubMed

Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM (2013) Cardiac perforation from implantable cardioverter-defibrillator lead placement: Insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 6(5):582–590. https://doi.org/10.1161/CIRCOUTCOMES.113.000299CrossRefPubMed

Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361(14):1329–1338. https://doi.org/10.1056/NEJMoa0906431CrossRefPubMed

Sedaghat-Hamedani F, Zitron E, Kayvanpour E, Lorenz HM, Katus HA, Meder B (2014) Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: A case report and a systematic review. Clin Res Cardiol 103(10):781–789. https://doi.org/10.1007/s00392-014-0716-0CrossRefPubMed

10.

Chao JAK, Firstenberg MS (2017) Delayed pacemaker lead perforations: Why unusual presentations should prompt an early multidisciplinary team approach. Int J Crit Illn Inj Sci 7(1):65–68. https://doi.org/10.4103/2229-5151.201951CrossRefPubMedPubMedCentral

11.

Sousa C, Martins E, Campelo M, Rangel I, Almeida PB, Maciel MJ (2014) Post-cardiac injury syndrome following transvenous pacing: Case report. Rev Port Cardiol 33(5):307.e1–307.e4. https://doi.org/10.1016/j.repc.2013.12.005CrossRef

12.

Imazio M, Hoit BD (2013) Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol 168(2):648–652. https://doi.org/10.1016/j.ijcard.2012.09.052CrossRefPubMed

13.

Cevik C, Wilborn T, Corona R, Schanzmeyer E, Nugent K (2009) Post-cardiac injury syndrome following transvenous pacemaker insertion: A case report and review of the literature. Heart Lung Circ 18(6):379–383. https://doi.org/10.1016/j.hlc.2009.04.001CrossRefPubMed

14.

Bernard ML, Shotwell M, Nietert PJ, Gold MR (2012) Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol 5(3):468–474. https://doi.org/10.1161/CIRCEP.111.969105CrossRefPubMedPubMedCentral

15.

Robinson J, Brigden W (1963) Immunological studies in the post-cardiotomy syndrome. Br Med J 2(5359):706–709 (http://www.ncbi.nlm.nih.gov/pubmed/2441377)CrossRefPubMedPubMedCentral

16.

Tabatznik B, Isaacs JP (1961) Postpericardiotomy syndrome following traumatic hemopericardium. Am J Cardiol 7:83–96 (http://www.ncbi.nlm.nih.gov/pubmed/13774734)CrossRefPubMed

17.

Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1. https://doi.org/10.1186/2046-4053-4-1CrossRefPubMedPubMedCentral

18.

Adler Y, Charron P, Imazio M et al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 36(42):2921–2964. https://doi.org/10.1093/eurheartj/ehv318CrossRefPubMed

19.

Imazio M, Adler Y (2013) Management of pericardial effusion. Eur Heart J 34(16):1186–1197. https://doi.org/10.1093/eurheartj/ehs372CrossRefPubMed

20.

Klein AL, Abbara S, Agler DA et al (2013) American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: Endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular computed tomography. J Am Soc Echocardiogr. https://doi.org/10.1016/j.echo.2013.06.023CrossRefPubMed

21.

Horr SE, Mentias A, Houghtaling PL et al (2017) Comparison of outcomes of pericardiocentesis versus surgical pericardial window in patients requiring drainage of pericardial effusions. Am J Cardiol 120(5):883–890. https://doi.org/10.1016/j.amjcard.2017.06.003CrossRefPubMed

22.

Danik SB, Mansour M, Singh J et al (2007) Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4(4):439–442. https://doi.org/10.1016/j.hrthm.2006.12.044CrossRefPubMed

23.

Ranasinghe I, Parzynski CS, Freeman JV et al (2016) Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: An observational cohort study. Ann Intern Med 165(1):20–29. https://doi.org/10.7326/M15-2732CrossRefPubMed

24.

Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R (2015) Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). Am Heart J 170(2):330–338. https://doi.org/10.1016/j.ahj.2015.02.025CrossRefPubMedPubMedCentral

25.

Friedman DJ, Singh JP, Curtis JP et al (2015) Comparative effectiveness of CRT-D versus defibrillator alone in HF patients with moderate-to-severe chronic kidney disease. J Am Coll Cardiol 66(23):2618–2629. https://doi.org/10.1016/j.jacc.2015.09.097CrossRefPubMed

26.

Gupta N, Kiley ML, Anthony F, Young C, Brar S, Kwaku K (2016) Multi-center, community-based cardiac Implantable electronic devices registry: Population, device utilization, and outcomes. J Am Heart Assoc 5(3):e2798. https://doi.org/10.1161/JAHA.115.002798CrossRefPubMedPubMedCentral

27.

Ohlow M‑A, Lauer B, Brunelli M, Geller JC (2013) Incidence and predictors of pericardial effusion after permanent heart rhythm device implantation: Prospective evaluation of 968 consecutive patients. Circ J 77(4):975–981 (http://www.ncbi.nlm.nih.gov/pubmed/23269085)CrossRefPubMed

28.

Elmouchi DA, Rosema S, Vanoosterhout SM et al (2014) Cardiac perforation and lead dislodgement after implantation of a MR-conditional pacing lead: A single-center experience. Pacing Clin Electrophysiol 37(1):4–10. https://doi.org/10.1111/pace.12293CrossRefPubMed

29.

Migliore F, Zorzi A, Bertaglia E et al (2014) Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 37(12):1602–1609. https://doi.org/10.1111/pace.12472CrossRefPubMed

30.

Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus GM (2012) Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: Insights from the National Cardiovascular Data Registry. J Am Heart Assoc 1(6):e3863. https://doi.org/10.1161/JAHA.112.003863CrossRefPubMedPubMedCentral

31.

Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 5(6):934–955. https://doi.org/10.1016/j.hrthm.2008.04.015CrossRefPubMed

32.

Raatikainen MJP, Arnar DO, Merkely B, Camm AJ, Hindricks G (2016) Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Europace 18(suppl 3):iii1–iii79. https://doi.org/10.1093/europace/euw244CrossRefPubMed

33.

Dyrda K, Piers SRD, van Huls van Taxis CF, Schalij MJ, Zeppenfeld K (2014) Influence of steroid therapy on the incidence of pericarditis and atrial fibrillation after percutaneous epicardial mapping and ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol 7(4):671–676. https://doi.org/10.1161/CIRCEP.113.001148CrossRefPubMed

34.

Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J (1999) Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med 341(27):2054–2059. https://doi.org/10.1056/NEJM199912303412704CrossRefPubMed

35.

Lee DS, Krahn AD, Healey JS et al (2010) Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 55(8):774–782. https://doi.org/10.1016/j.jacc.2009.11.029CrossRefPubMed

36.

Ezzat VA, Lee V, Ahsan S et al (2015) A systematic review of ICD complications in randomised controlled trials versus registries: Is our “real-world” data an underestimation? Open Heart 2(1):e198. https://doi.org/10.1136/openhrt-2014-000198CrossRefPubMedPubMedCentral

Titel: Pericardial complications and postcardiac injury syndrome after cardiovascular implantable electronic device placement
A meta-analysis and systematic review
verfasst von: B. R. Verma, MD
K. Banerjee, MD
A. Noll, MD
C. K. Ala, MD
M. Badar, MD
D. Kwon, MD
C. L. Jellis, MD
R. Hachamovitch, MD
A. Hussein, MD
Dr. A. L. Klein, MD
Publikationsdatum: 10.05.2019
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe Sonderheft 1/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-019-4807-6

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2020

Predictive value of fibrinogen-to-albumin ratio in acute coronary syndrome

Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathy

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome

Prevalence of TTN mutations in patients with dilated cardiomyopathy